World Cell & Gene Therapy Summit South Korea 2026

 

South Korea’s cell and gene therapy landscape is highly dynamic, as observed from regulatory approvals, clinical trial progress, and manufacturing activity, from over 150 companies in active drug development. Additionally, with global pharma including Bayer, Novartis and more seeing strategic investments into the CGT space within South Korea, greater opportunities for scientific innovation and technology advancement are yet to come.

The inaugural World Cell & Gene Therapy Summit South Korea is an exclusive opportunity to connect with global pharma and leading Korean biotech showcasing the latest trends in autologous, allogeneic, in vivo, and gene editing therapies to help you identify gaps within your programs and set the roadmap of CGT development in 2026/2027.

Join 90+ world-class international experts including T-Knife Therapeutics, Bionoxx, Byterna Therapeutics and more, to progress early proof-of-concept CAR-TCR, genome editing and RNA-based cell and gene therapies to patients faster.

This event is part of the World Advanced Therapeutics Summit South Korea by Hanson Wade, so attendees will also have access to sessions for the 2^nd World RNA-Based Therapeutics & Vaccines Summit South Korea.

More Info

---

---